The choice between a ritonavir-boosted protease inhibitor- and a non-nucleoside reverse transcriptase inhibitor-based regimen for initiation of antiretroviral treatment – results from an observational study in Germany

類似資料

• Ritonavir-Boosted Darunavir Plus Two Nucleoside Reverse Transcriptase Inhibitors versus Other Regimens for Initial Antiretroviral Therapy for People with HIV Infection: A Systematic Review
  著者:: Balayan, Tatevik, 等
  出版事項: (2017)
• Long-lasting protection of activity of nucleoside reverse transcriptase inhibitors and protease inhibitors (PIs) by boosted PI containing regimens.
  著者:: Alexandra U Scherrer, 等
  出版事項: (2012-01-01)
• Long-Lasting Protection of Activity of Nucleoside Reverse Transcriptase Inhibitors and Protease Inhibitors (PIs) by Boosted PI Containing Regimens
  著者:: Scherrer, Alexandra U., 等
  出版事項: (2012)
• Correction: Long-Lasting Protection of Activity of Nucleoside Reverse Transcriptase Inhibitors and Protease Inhibitors (PIs) by Boosted PI Containing Regimens
  著者:: Scherrer, Alexandra U., 等
  出版事項: (2013)
• Unemployment, health, and education of HIV-infected males in Germany
  著者:: Groß, Mona, 等
  出版事項: (2015)